| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | €1.1343 | -3.65% | €188.52M | €650.91K | |
| €2.3803 | -0.72% | €186.87M | €1.86K | |
MFM Aberdeen Municipal Income Fund | €4.4684 | -1.33% | €186.87M | €227.13K | |
CHCI Comstock Holding Companies, Inc. Class A | €17.8563 | -0.91% | €186.86M | €107.31K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | €8.5758 | +0.40% | €186.84M | €5.24K | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | €4.6488 | -7.04% | €186.59M | €11.96K | |
EXFY Expensify, Inc. Class A Common Stock | €1.9678 | -3.38% | €186.48M | €346.96K | |
| €54.4667 | +0.63% | €186.29M | €11.17K | |
IIF Morgan Stanley India Investment Fund, Inc. | €19.4374 | -0.83% | €186.16M | €11.73K | |
VYGR Voyager Therapeutics, Inc. Common Stock | €2.7927 | -4.41% | €185.84M | €384.78K | |
MITT TPG Mortgage Investment Trust, Inc. | €5.8432 | +0.30% | €185.83M | €223.85K | |
| €1.4616 | +9.04% | €185.37M | €2.40M | |
PEPG PepGen Inc. Common Stock | €2.7240 | -1.25% | €185.09M | €942.56K | |
PLX Protalix BioTherapeutics, Inc. Common Stock | €2.2943 | +0.76% | €184.85M | €469.89K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | €9.0312 | -0.38% | €184.72M | €28.35 | |
